Chester Kao et al. evaluated the predictive value of TMB, PD-L1, and neutrophil–lymphocyte ratio (NLR) for the response to ICIs in 88 NSCLC patients [88]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.